AI Morbidity and Mortality (AI M&M) is a structured, blameless framework designed to review clinical AI failures. It combines standardized case intake, evidence preservation, investigator reconstruction, tool‑in‑loop attribution, and corrective‑action tracking, classifying each event across four linked dimensions: Trigger, Mechanism, Clinical Pathway, and Corrective Action. The authors demonstrate the framework with five outpatient medication and clinical decision‑support cases, achieving full agreement among reviewers on all classification axes.
By Paulius Mui, Dean F. Sittig, Steve Labkoff, Sanjay Basu
arXiv:2606. 28692v1 Announce Type: new Abstract: Treatment reasoning underpins every therapeutic decision, integrating disease context, comorbidities, medications, contraindications, and evolving biomedical knowledge to select an appropriate therapy.
By Shanghua Gao, Ayush Noori, Richard Zhu, Curtis Ginder, Zhenglun Kong, Xiaorui Su, Justin Kauffman, Benjamin S. Glicksberg, Joshua Lampert, Ankit Sakhuja, Ashwin Sawant, ATHENA-R1 Evaluation Consortium, David A. Clifton, Noa Dagan, Ran Balicer, Marinka Zitnik
FLARE is a systematic, uncertainty‑aware framework that evaluates the financial and operational implications of adopting AI in healthcare. It integrates fuzzy logic, time‑driven activity‑based costing, and return‑on‑investment analysis to estimate costs of clinical service delivery, AI development and operation, and the economic impact of workflow integration. A case study on AI‑assisted large vessel occlusion detection in the CT stroke pathway demonstrated that FLARE can quantify conventional pathway costs, AI‑related costs, and AI‑enabled savings, identifying a break‑even threshold of about 3,992 patients per year and a positive first‑year ROI at typical stroke volumes of 5,000 patients.
By Jacob Idoko, Siddhartha Paudel, Mariana Bento, Roberto Souza, Gouri Ginde
arXiv:2607. 12527v1 Announce Type: new Abstract: Musculoskeletal diseases are among the leading causes of disability worldwide and create the greatest global need for rehabilitation.
By Wenjie Li, Yujie Zhang, Fanrui Zhang, Haoran Sun, Renhao Yang, Junjun He, Weiran Huang, Yuanfeng Ji, Chenrun Wang, Kailing Wang, Hongcheng Gao, Kaipeng Zhang, Hanyu Wang, Angela Lin Wang, Xingqi He, Yilin Huang, Shiyi Yao, Lilong Wang, Yankai Jiang, Yirong Chen, Chenglong Ma, Jiyao Liu, Ming Hu, Gen Li, Yidong Xu, Chengyu Zhuang, Jiawei Liu, Yin Zhang, Lequan Yu, Lu Chen, Yinpeng Dong, Lei Liu, Carlos Gutierrez Sanroman, Yu Qiao, Weijie Ma, Xiaosong Wang, Lei Wang
arXiv:2512. 01241v4 Announce Type: replace-cross Abstract: Large language models (LLMs) and medical AI tools are routinely used by physicians and patients for medical advice, yet their clinical safety profiles remain poorly characterized.
By David Wu, Fateme Nateghi Haredasht, Saloni Kumar Maharaj, Priyank Jain, Jessica Tran, Matthew Gwiazdon, Arjun Rustagi, Jenelle Jindal, Jacob M. Koshy, Vinay Kadiyala, Anup Agarwal, Bassman Tappuni, Brianna French, Sirus Jesudasen, Christopher V. Cosgriff, Rebanta Chakraborty, Jillian Caldwell, Susan Ziolkowski, David J. Iberri, Robert Diep, Rahul S. Dalal, Kira L. Newman, Kristin Galetta, J. Carl Pallais, Nancy Wei, Kathleen M. Buchheit, David I. Hong, Vartan Pahalyants, Ernest Y. Lee, Allen Shih, Tamara B. Kaplan, Vishnu Ravi, Sarita Khemani, Thomas A. Buckley, April S. Liang, Daniel Shirvani, Advait Patil, Nicholas Marshall, Kanav Chopra, Joel Koh, Adi Badhwar, Anastasia Perez, Austin J. Schoeffler, Mahbuba Tusty, Chase M. Walton, Liam G. McCoy, David J. H. Wu, Yingjie Weng, Sumant Ranji, Kevin Schulman, Nigam H. Shah, Jason Hom, Arnold Milstein, Arjun K. Manrai, Adam Rodman, Jonathan H. Chen, Ethan Goh
arXiv:2512. 01241v3 Announce Type: replace-cross Abstract: Large language models (LLMs) are routinely used by physicians and patients for medical advice, yet their clinical safety profiles remain poorly characterized.
By David Wu, Fateme Nateghi Haredasht, Saloni Kumar Maharaj, Priyank Jain, Jessica Tran, Matthew Gwiazdon, Arjun Rustagi, Jenelle Jindal, Jacob M. Koshy, Vinay Kadiyala, Anup Agarwal, Bassman Tappuni, Brianna French, Sirus Jesudasen, Christopher V. Cosgriff, Rebanta Chakraborty, Jillian Caldwell, Susan Ziolkowski, David J. Iberri, Robert Diep, Rahul S. Dalal, Kira L. Newman, Kristin Galetta, J. Carl Pallais, Nancy Wei, Kathleen M. Buchheit, David I. Hong, Vartan Pahalyants, Ernest Y. Lee, Allen Shih, Tamara B. Kaplan, Vishnu Ravi, Sarita Khemani, Thomas A. Buckley, April S. Liang, Daniel Shirvani, Advait Patil, Nicholas Marshall, Kanav Chopra, Joel Koh, Adi Badhwar, Anastasia Perez, Austin J. Schoeffler, Mahbuba Tusty, Chase M. Walton, Liam G. McCoy, David J. H. Wu, Yingjie Weng, Sumant Ranji, Kevin Schulman, Nigam H. Shah, Jason Hom, Arnold Milstein, Arjun K. Manrai, Adam Rodman, Jonathan H. Chen, Ethan Goh
arXiv:2607. 15394v1 Announce Type: new Abstract: Black-box models limit the adoption of artificial intelligence in medicine due to their lack of interpretability and reproducibility.
By Antony Garcia, Adrian Noriega, Gabrielle Britton, Xinming Huang
The paper presents a lightweight, smartphone-based safety‑check system designed to detect adverse drug reactions (ADRs) in rural Bangladeshi public hospitals where electronic health records are absent. By recording a patient’s phone number as a soft identifier, capturing prescription images, resolving brand names to active ingredients, and matching these against the patient’s recorded severe reaction history, the system flags only high‑risk matches to mitigate alert fatigue. The authors outline a feasibility study framework that will evaluate workflow fit, usability, identity‑resolution reliability, and retrospective detection of known reaction cases, explicitly noting that clinical‑outcome effects are beyond the scope of this single‑site study.
By Shahir Abdullah
arXiv:2607. 08038v1 Announce Type: new Abstract: Diagnostic error is a major threat to patient safety, yet current large language model (LLM) systems often treat diagnosis as a one-shot prediction task, lacking safeguards against missed high-risk alternatives or rigorous verification of their reasoning.
By Fan Ma, Mauro Giuffr\`e, Donald Wright, Kent McCann, Mark Iscoe, Lingfei Qian, Mingyang Jiang, Chi Wing Ng, Na Hong, Huan He, Cathy Shyr, Qingyu Chen, Lee Schwamm, Lucila Ohno-Machado, Hua Xu
arXiv:2607. 20542v1 Announce Type: cross Abstract: A critical challenge in healthcare systems in low- and middle-income countries (LMICs) is the efficient and equitable allocation of scarce resources, particularly essential medicines.
By Angel Tsai-Hsuan Chung, Jatu Abdulai, Patrick Bayoh, Lawrence Sandi, Francis Smart, Hamsa Bastani, Osbert Bastani
arXiv:2407. 11823v4 Announce Type: replace Abstract: The United States Food and Drug Administration's (FDA's) 510(k) pathway allows manufacturers to gain medical device approval by demonstrating substantial equivalence to a legally marketed device.
By Mohammad Zhalechian, Soroush Saghafian, Omar Robles
arXiv:2606. 26205v1 Announce Type: new Abstract: Patients increasingly seek medication information online, yet safety knowledge for psychiatric drugs is split between regulatory adverse-event records, which are authoritative but abstract, and patient narratives, which are experience-near but unvalidated.
By Huizi Yu, Jian Liu, Wenkong Wang, Lingyao Li, Jiayan Zhou, Zhaoqian Xue, Xiang Li, Xinxin Lin, Zhiying Liang, Zhuoru Wu, Siyuan Ma, Xin Ma, Lizhou Fan